公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases | Cheng, Pin-Nan; WEN-JONE CHEN ; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; TSUNG-HSIEN LIN ; JIA-HORNG KAO ; TZUNG-DAU WANG ; Liu, Ping-Yen; YEN-WEN WU ; CHUN-JEN LIU | Clinical and molecular hepatology | | | |
2019 | Taiwan consensus statement on the management of chronic hepatitis B | Chien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI ; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F. | Journal of the Formosan Medical Association | 50 | 47 | |
2008 | Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma | Chou Y.-C.; MING-WHEI YU ; Wu C.-F.; Yang S.-Y.; Lin C.-L.; CHUN-JEN LIU ; Shin W.-L.; PEI-JER CHEN ; Liaw Y.-F.; Chen C.-J. | Gut | 101 | 95 | |
2024 | Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes | HUEY-LING CHEN ; CHIEN-NAN LEE ; Chang, Chin-Hao; Lai, Ming-Wei; Tsai, Ming-Chieh; Mu, Shu-Chi; CHUN-JEN LIU ; JIN-CHUNG SHIH ; Wen, Wan-Hsin; Hu, Rui-Ting; Huang, Chun-Pin; Hu, Kuang-Chun; Chen, Chie-Pein; Lee, Chyi-Long; Chien, Rong-Nan; Chang, Kai-Chi; HONG-YUAN HSU ; CHIEN-CHANG LEE ; YEN-HSUAN NI ; MEI-HWEI CHANG | Liver international : official journal of the International Association for the Study of the Liver | | | |
2024 | Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy | Chang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2005 | Therapeutic implications of hepatitis B virus genotypes | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 108 | 82 | |
2013 | Transabdominal ultrasound finding and acute hepatocellular injury in different cohorts of elderly adults with and without common bile duct stones | Hu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of the American Geriatrics Society | 1 | 1 | |
2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
2012 | Treatment of hepatitis C virus infection: Past, present and future | CHUN-JEN LIU ; DING-SHINN CHEN | Chronic Hepatitis B and C: Basic Science to Clinical Applications | 0 | 0 | |
2014 | Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality | CHUN-JEN LIU ; Chu, Y.-T.; Shau, W.-Y.; Kuo, R.N.; PEI-JER CHEN ; Lai, M.-S. | Gut | 46 | 39 | |
2014 | Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues | CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 21 | 17 | |
1989 | Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy | Tzeng C.-H.; Chen P.-M.; Chuang M.-W.; Liu J.-H.; Hsieh R.-K.; CHUN-JEN LIU ; Fan S.; Chen K.Y.; Yung C.-H.; Wang S.-Y.; Chau W.-K.; Ching K.-N. | Chinese Medical Journal (Taipei) | 4 | 0 | |
2013 | Treatment options for dual HCV/HBV coinfection | CHUN-JEN LIU ; JIA-HORNG KAO | Emerging Therapeutic Options for Hepatitis C | 0 | 0 | |
2020 | Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials | Asahina Y.; CHUN-JEN LIU ; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN ; Enomoto N. | Hepatology Research | 6 | 6 | |
2014 | Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection | CHUN-JEN LIU ; PEI-JER CHEN | World Journal of Gastroenterology | 21 | 19 | |
2014 | Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin | Chen M.-Y.; CHEN-HUA LIU ; Chen T.-C.; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 8 | 7 | |
2017 | Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B | HUNG-CHIH YANG ; Shih Y.-F; CHUN-JEN LIU | Journal of Infectious Diseases | 7 | 7 | |
2006 | Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin F.-Y.; Wang T.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 37 | 35 | |
2008 | Viral hepatocarcinogenesis: From infection to cancer | Tan A.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; Cheung C.; PEI-JER CHEN | Liver International | 102 | 84 | |